Merck & Co Inc (MRK)

MRK (NYSE:Drugs) EQUITY
$62.85
pos +0.00
+0.00%
Today's Range: 62.18 - 62.99 | MRK Avg Daily Volume: 9,991,600
Last Update: 08/26/16 - 4:00 PM EDT
Volume: 0
YTD Performance: 18.99%
Open: $0.00
Previous Close: $62.32
52 Week Range: $47.97 - $64.00
Oustanding Shares: 2,765,208,203
Market Cap: 172,327,775,211
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 4 5 5
Moderate Buy 0 0 0 0
Hold 7 8 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.08 2.33 2.17 2.17
Latest Dividend: 0.46
Latest Dividend Yield: 2.95%
Dividend Ex-Date: 09/13/16
Price Earnings Ratio: 34.24
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
34.24 34.40 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
11.46% 15.49% 31.98%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.50 -0.20 -0.06
Net Income -62.60 -0.30 -0.11
EPS -61.70 -0.20 -0.08
Earnings for MRK:
EBITDA 13.92B
Revenue 39.50B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $0.98 $0.95 $3.74 $3.75
Number of Analysts 6 5 10 10
High Estimate $1.01 $0.97 $3.78 $3.89
Low Estimate $0.96 $0.92 $3.68 $3.49
Prior Year $0.96 $0.93 $3.59 $3.74
Growth Rate (Year over Year) 2.43% 1.72% 4.04% 0.54%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Jim Collins

 | Aug 12, 2016 | 11:00 AM EDT
Besides Tesla, Twitter and Biogen make good candidates.
By

Tim Melvin

 | Aug 9, 2016 | 2:00 PM EDT
There's a price to pay for low expectations.
By

Chris Laudani

 | Aug 9, 2016 | 10:00 AM EDT
BMY is unlikely to stay in the low $60s for long.
By

Jim Cramer and Jack Mohr

 | Aug 8, 2016 | 3:39 PM EDT
The failed trial is among the biggest single blows by a major pharma player.
By

James Passeri

 | Aug 8, 2016 | 12:43 PM EDT
Rising crude prices help buoy a host of oil companies Monday.
By

Bruce Kamich

 | Aug 8, 2016 | 10:03 AM EDT
One day does not make a trend, but one day can certainly reinforce an existing trend.
By

Anders Keitz

 | Aug 8, 2016 | 8:16 AM EDT
Mattress Firm soars on takeover bid, while Delta's worldwide computer issues are causing the stock to drop.

bullishMerck upgraded at Credit Suisse

Aug 8, 2016 | 7:16 AM EDT
MRK was upgraded to Outperform, Credit Suisse said. $73 price target. Keytruda stands to benefit from recent setback for Opdivo.
By

Timothy Collins

 | Aug 7, 2016 | 8:30 PM EDT
BMY's loss definitely looks like MRK's gain.
By

Doug Kass

 | Aug 5, 2016 | 5:39 PM EDT
The U.S. dollar strengthened in response to the good jobs report, up 0.75% for the week. The price of crude oil was flat, near $42, after yesterday's smart rally. Gold got schmeissed, down $25 to $1,342. I am watching for a buy entry point but rate differentials and a stronger U.S. currency could pressure precious metals in the near term. See Ben Cross below. Agricultural commodities: wheat +13, corn +2, soybeans +18. Lumber +6. Bonds were hit hard. Short bonds is now my largest investment position. iShares 20+ Year Treasury Bond ETF (TLT) was down $1.45. The yield on the 10-year U.S. note rose by nine basis points to 1.59% and the long bond by six basis points to 2.32%. The 2s/10s spread expanded by two basis points to 87 basis points, aiding financial stocks. Municipals got hit and closed-end muni bond funds suffered. Banks were standout beneficiaries from the jobs report. I covered my Financial Select Sector SPDR ETF (XLF) short trade earlier this week. Brokerages were higher. Life insurers rebounded from MetLife (MET) inspired weakness on Thursday. In pharma, Merck (MRK) and Bristol-Myers Squibb (BMY) provided the fireworks, with the former up 10%-plus and the latter down 16%. Retail was inspired by better jobs numbers. Nordstrom (JWN) , my principal short, reversed earlier-week weakness. Old tech was boring, doing little. Autos were up, but only modestly. Media was better. Consumer staples suffered under the weight of a strong U.S. dollar Ag equipment was better, coincident with rising ag commodities. (T)FANG was better, but only modestly so, save Tesla, which was lower. In individual stocks, my long Twitter (TWTR) continued higher. ProShares UltraShort S&P 500 ETF (SDS) , my Trade of the Week, fell by 1.7%. Not so good. Here are several value-added contributions on our site today: Jim "El Capitan" Cramer on the jobs reports supporting the market's gains.  Ben "Goldfinger" Cross on another buying opportunity in gold. I read this one twice! "Big" James Gentile on "what gives" with this market?  Ed Ponsi "Scheme" on "will the real Tesla stand up?"  Rev Shark on getting the market "juiced." Enjoy the weekend!
The dollar index ended up holding support nicely into both the time and price parame...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.